 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/364797
World Cancer Assay Markets
|
Description: |
Cancer Assays Pave Way for Hybridization Technology's Success
The field of cancer assays has evolved tremendously over the years, with focus shifting from immunoassays to assessing the genetic basis of cancer. Immunoassays detect the presence of tumor markers secreted by cancer cells and operate on the premise of an antibody identifying an analyte as its antigen. Hybridization technology is now being applied to the identification of
mutations responsible for cancer development. Widespread adoption is forecast, as this technology becomes increasingly reliable as a means of cancer evaluation.
This Frost & Sullivan study provides a comprehensive analysis of the world cancer assay markets. By identifying emerging technology trends and supplying
strategic recommendations, this research allows your company to optimize revenues within this burgeoning field.
Human Genome Project Drives Industry Developments
The Human Genome Project has generated a tremendous amount of information regarding the makeup and structure of the human genome—the implications of which are incredible for the future of medicine in the areas of
diagnosis, prognosis, and treatment of cancer, states the study's author. Completion of the initial mapping of the human genome is a significant accomplishment, laying the initial groundwork for further research.
Results of the Human Genome Project only serve as background knowledge for deciphering the information obtained. Attention is now focused on the area of functional genomics, and identifying specific gene purpose and expression levels as it relates to the disease, which is expected to positively influence market growth.
Less Invasive Procedures Encourage Genetic Testing
Genetic testing serves as an alternative to traditional procedures, providing more informative results and less invasive procedures. For example, testing for cervical cancer usually involves a Pap test, which is then examined for cellular changes and often followed by a colonoscopy, biopsy, or surgery. PAP tests often yield false-negative results or fail altogether. Genetic testing for cervical cancer generates a greater degree of accuracy and only recommends invasive, costly follow-up procedures when the test indicates a high risk of cancer, says the author.
This Frost & Sullivan research provides the most up-to-date intelligence on the world cancer assays markets, enabling participants to implement effective business strategies for future success.
Additional Information
Market Participants
Affymetrix, Inc.
BD Biosciences Clontech
Cambio, Inc.
Cytocell, Ltd.
Digene Corporation
Genzyme Corporation
Myriad Genetics, Inc.
Ventana Medical Systems, Inc.
Vysis, Inc.
Related Companies
Agilent Technologies
Corning, Inc.
DiagnoCure, Inc.
Exact Sciences Corporation
Incyte Genomics, Inc.
Laboratory Corporation of America Holdings
Millenium Pharmaceuticals, Inc.
Nanogen, Inc.
Quest Diagnostics, Inc.
ResGen/Invitrogen Corporation
|
|
Contents: |
1. Executive Summary
A. Introduction
1. Market Overview
2. Hybridization Technology Market
A. Total Market Overview: Definitions
1. Introduction
2. Market Engineering Analysis
3. Research Methodology
B. Drivers Restraints and Technology Trends
1. Market Drivers
2. Market Restraints
3. Technology Trends
C. Demand Product and Pricing Analysis
1. Demand Analysis
2. Product Analysis
3. Pricing Analysis
D. Total Competitive Structure Revenue Forecasts and Market Share Analysis
1. Total Competitive Structure
2. Total Revenue Forecasts
3. Total Market Share Analysis
E. North America Market
1. Competitive Structure
2. Revenue Forecasts
F. Western Europe Market
1. Competitive Structure
2. Revenue Forecasts
G. Japan Market
1. Competitive Structure
2. Revenue Forecasts
H. Rest of World Market
1. Competitive Structure
2. Revenue Forecasts
I. Challenges Strategies and Awards
1. Challenges
2. Strategies
3. Market Engineering Leadership Award
3. Sequencing Technology Market
A. Total Market Overview: Definitions
1. Introduction
2. Market Engineering Analysis
3. Research Methodology
B. Drivers Restraints and Technology Trends
1. Market Drivers
2. Market Restraints
3. Technology Trends
C. Demand Product and Pricing Analysis
1. Demand Analysis
2. Product Analysis
3. Pricing Analysis
D. Total Competitive Structure Revenue Forecasts and Market Share Analysis
1. Total Competitive Structure
2. Total Revenue Forecasts
3. Total Market Share Analysis
E. North American Market
1. Competitive Structure
2. Revenue Forecasts
F. Western European Market
1. Competitive Structure
2. Revenue Forecasts
G. Japanese Market
1. Competitive Structure
2. Revenue Forecasts
H. Challenges Strategies and Awards
1. Challenges
2. Strategies
3. Business Development Strategy Award
4. Microarray Market
A. Total Market Overview: Definitions
1. Introduction
2. Market Engineering Analysis
3. Research Methodology
B. Drivers Restraints and Technology Trends
1. Market Drivers
2. Market Restraints
3. Technology Trends
C. Demand Product and Pricing Analysis
1. Demand Analysis
2. Product Analysis
3. Pricing Analysis
D. Total Competitive Structure Revenue Forecasts and Market Share Analysis
1. Total Competitive Structure
2. Total Revenue Forecasts
3. Total Market Share Analysis
E. North America Market
1. Competitive Structure
2. Revenue Forecasts
F. Western Europe Market
1. Competitive Structure
2. Revenue Forecasts
G. Japan Market
1. Competitive Structure
2. Revenue Forecasts
H. Rest of World Market
1. Competitive Structure
2. Revenue Forecasts
I. Challenges Strategies and Awards
1. Challenges
2. Strategies
3. Product Line Strategy Award
5. Feedback
A.Feedback Process
1. Introduction
2.Feedback Form
List Of Figures
Chapter 2
Cancer Assay Market: Cases of Cancer by Geographic Region (World), 2000
Cancer Assay Market: Deaths from Cancer by Geographic Region (World), 2000
Cancer Assay Market: Number of Cancer Cases by Type (World), 2000
Cancer Assay Market: Number of Cancer Deaths by Type (World), 2000
Cancer Assay Market: Genes Identified with Cancer (World), 2000
Hybridization Technology Segment: Market Drivers Ranked in Order of Impact (World), 2001-2007
Hybridization Technology Segment: Market Restraints Ranked in Order of Impact (World), 2001-2007
Hybridization Technology Segment: Products Offered by Major Market Participants (World), 2000
Hybridization Technology Segment: Competitive Structure (World), 2000
Hybridization Technology Segment: Revenue Forecasts (World), 1997-2007
Hybridization Technology Segment: Revenue Percentages by Geographic Region (World), 1997-2007
Hybridization Technology Segment: Market Share Trends of Major Market Participants (World), 1999-2000
Hybridization Technology Segment: Revenue Forecasts (North America), 1997-2007
Hybridization Technology Segment: Revenue Forecasts (Western Europe), 1997-2007
Hybridization Technology Segment: Revenue Forecasts (Japan), 1997-2007
Hybridization Technology Segment: Revenue Forecasts (Rest of World), 1997-2007
Hybridization Technology Segment: Impact of Industry Challenges (World), 2001-2007
Chapter 3
Sequencing Technology Segment: Market Drivers Ranked in Order of Impact (World), 2001-2007
Sequencing Technology Segment: Market Restraints Ranked in Order of Impact (World), 2001-2007
Sequencing Technology Segment: Products Offered by Major Market Participants (World), 2000
Sequencing Technology Segment: Competitive Structure (World), 2000
Sequencing Technology Segment: Revenue Forecasts (World), 1997-2007
Sequencing Technology Segment: Revenue Percentages by Geographic Region (World), 1997-2007
Sequencing Technology Segment: Market Share Trends of Major Market Participants (World), 1999-2000
Sequencing Technology Segment: Revenue Forecasts (North America), 1997-2007
Sequencing Technology Segment: Revenue Forecasts (Western Europe), 1997-2007
Sequencing Technology Segment: Revenue Forecasts (Japan), 1997-2007
Sequencing Technology Segment: Impact of Industry Challenges (World), 2001-2007
Chapter 4
Micorarray Segment: Market Drivers Ranked in Order of Impact (World), 2001-2007
Microarray Segment: Market Restraints Ranked in Order of Impact (World), 2001-2007
Microarray Segment: Products Offered by Major Market Participants (World), 2000
Microarray Segment: Competitive Structure (World), 2000
Microarray Segment: Revenue Forecasts (World), 1997-2007
Microarray Segment: Revenue Percentages by Geographic Region (World), 1997-2007
Microarray Segment: Market Share Trends of Major Market Participants (World), 1999-2000
Microarray Segment: Revenue Forecasts (North America), 1997-2007
Microarray Segment: Revenue Forecasts (Western Europe), 1997-2007
Microarray Segment: Revenue Forecasts (Japan), 1997-2007
Microarray Segment: Revenue Forecasts (Rest of World), 1997-2007
Microarray Segment: Impact of Industry Challenges (World), 2001-2007
|
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/364797
Order by Fax - using the order form below
Order By Post - print the order form below and send to
|
|
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2
Printed 25/11/2009 21:53:19 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
|
Product Name: |
World Cancer Assay Markets
|
|
Web Address: |
http://www.researchandmarkets.com/reports/364797
|
|
Office Code: |
|
OC8HJNMPMSTQQ
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Site License
|
|
€2,653.00
|
|
Electronic (PDF)
- Enterprisewide
|
|
€3,660.00
|
|
Electronic and Hard Copy (PDF)
- Enterprisewide
|
|
€3,996.00 + EUR€ 50.00 Shipping/Handling *
|
|
Electronic and Hard Copy (PDF)
- Site License
|
|
€2,989.00 + EUR€ 50.00 Shipping/Handling *
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
|
|
|
First Name: |
Last Name: |
|
Email Address: |
|
|
Job Title: |
|
|
Organisation: |
|
|
Address: |
|
|
City: |
|
|
Postal/Zip Code: |
|
|
Country: |
|
|
Phone Number: |
|
|
Fax Number: |
|
|
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
|
Page 2 of 2
Printed 25/11/2009 21:53:19
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
|
American Express
|
|
|
Diners Club
|
|
|
Master Card
|
|
|
Visa
|
|
|
|
|
|
|
Cardholder's Name: |
|
|
|
|
Cardholder's Signature: |
|
|
|
|
Expiry Date: |
/ |
|
|
|
Card Number: |
|
|
|
|
CVV Security Code: |
|
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
|
|
|
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
|
|
|
|
Please transfer funds to:
|
|
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
|
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
|
|
|
|
|
